Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jemal

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2000
Disposition of radiolabeled ifetroban in rats, dogs, monkeys, and humansR C Dockens, K S Santone, J G Mitroka, et al.
Clinical Pharmacology and Therapeutics|October 3, 2000
Disposition and safety of omapatrilat in subjects with renal impairmentD A Sica, W Liao, T W Gehr, et al.
Journal of Clinical Pharmacology|January 5, 2002
Pharmacodynamics and pharmacokinetics of omapatrilat in heart failureJ B Kostis, M Klapholz, C Delaney, et al.
The AAPS Journal|October 24, 2014
Tiered approaches to chromatographic bioanalytical method performance evaluation: recommendation for best practices and harmonization from the Global Bioanalysis Consortium harmonization teamS Lowes, R Hucker, M Jemal, et al.
CA: a Cancer Journal for Clinicians|September 21, 2021
Cancer statistics for the US Hispanic/Latino population, 2021Kimberly D Miller, Ana P Ortiz, Paulo S Pinheiro, et al.
Journal of Clinical Pharmacology|September 21, 2001
Fosinopril: pharmacokinetics and pharmacodynamics in Chinese subjectsP Y Ding, K M Chu, O Y Hu, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2000
Disposition of radiolabeled ifetroban in rats, dogs, monkeys, and humansR C Dockens, K S Santone, J G Mitroka, et al.
Clinical Pharmacology and Therapeutics|October 3, 2000
Disposition and safety of omapatrilat in subjects with renal impairmentD A Sica, W Liao, T W Gehr, et al.
Journal of Clinical Pharmacology|January 5, 2002
Pharmacodynamics and pharmacokinetics of omapatrilat in heart failureJ B Kostis, M Klapholz, C Delaney, et al.
The AAPS Journal|October 24, 2014
Tiered approaches to chromatographic bioanalytical method performance evaluation: recommendation for best practices and harmonization from the Global Bioanalysis Consortium harmonization teamS Lowes, R Hucker, M Jemal, et al.
CA: a Cancer Journal for Clinicians|September 21, 2021
Cancer statistics for the US Hispanic/Latino population, 2021Kimberly D Miller, Ana P Ortiz, Paulo S Pinheiro, et al.
Journal of Clinical Pharmacology|September 21, 2001
Fosinopril: pharmacokinetics and pharmacodynamics in Chinese subjectsP Y Ding, K M Chu, O Y Hu, et al.
Pageof 6